Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024

SELL
$69.51 - $104.43 $695 - $1,044
-10 Reduced 0.5%
2,000 $198,000
Q3 2022

Oct 25, 2022

BUY
$118.07 - $194.18 $236,140 - $388,360
2,000 Added 20000.0%
2,010 $238,000
Q3 2021

Oct 28, 2021

BUY
$221.9 - $484.47 $2,219 - $4,844
10 New
10 $4,000
Q1 2021

Apr 22, 2021

SELL
$109.18 - $185.98 $1,419 - $2,417
-13 Closed
0 $0
Q4 2020

Feb 05, 2021

BUY
$65.74 - $169.86 $854 - $2,208
13 New
13 $1,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Destiny Wealth Partners, LLC Portfolio

Follow Destiny Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Destiny Wealth Partners, LLC with notifications on news.